Boston Scientific has won a maximum $135.7M indefinite-delivery, indefinite-quantity contract for cardiovascular procedural packages and ancillary items. The five-year contract carries no option periods, with the ordering period running through September 29, 2031. The products will support the U.S. Army, Navy, and Air Force, funded by fiscal 2026–2031 Defense Working Capital Funds. The Defense Logistics Agency Troop Support is the contracting activity.
Boston Scientific CorpBoston Scientific won a $135.7M U.S. defense health contract for cardiovascular procedural packages supporting Army, Navy, and Air Force.
